Corentin Orvain

5PUBLICATIONS
27CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 11, 2026
Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.

Gaspar Aspas Requena, Pau Montesinos, Emilie Bérard

|Jul 10, 2021
Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations.

Valentin Lacombe, Christopher Nunes Gomes, Jean-Baptiste Robin

|Apr 18, 2020
R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment: A eight-year trajectory study.

Carole Lacout, Corentin Orvain, Valérie Seegers

|Jul 15, 2018
Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.

Anne Bouvier, Bénédicte Ribourtout, Sylvie François

|Jul 04, 2018
Inherited or acquired modifiers of iron status may dramatically affect the phenotype in dehydrated hereditary stomatocytosis.

Corentin Orvain, Lydie Da Costa, Richard Van Wijk

Pageof 1